The period for CME/CE credit for this activity has expired.

The American Journal Of Medicine

Found in Translation

INSTRUCTIONS

To complete this activity please view the webcast, complete the demographic questionnaire, CME posttest, and evaluation, and a continuing education certificate will automatically be generated for you to print or save to your computer for your records.

Thank you for your participation.


CME Information

Found in Translation: Insulin Therapy and Glycemic Pattern Recognition in Clinical Practice

Release date: January 26, 2013
Expiration date: January 26, 2014

Faculty
Sam Dagogo-Jack, MD, FRCP - Program Chair
Mullins Professor and Director
Division of Endocrinology, Diabetes & Metabolism
Director, Clinical Research Center
University of Tennessee Health Science Center
Memphis, Tennessee

John E Anderson, MD
President
The Frist Clinic
Nashville, Tennessee

Javier Morales, MD
Vice President
Principal Trials Investigator
Advanced Internal Medicine Group, PC
New Hyde Park, New York

Geralyn Spollett, MSN, ANP-CS, CDE
Associate Director
Adult Nurse Practitioner
Yale Diabetes Center
Yale School of Medicine
New Haven, Connecticut

Intended Audience
This activity is intended for family physicians and HCPs involved in the management of patients with type 2 diabetes.

Learning Objectives
At the conclusion of this activity, participants should be able to:

  • Interpret SMBG data presented in different formats
  • Summarize clinical trial evidence supporting stepwise insulin intensification in T2DM
  • Explain how to adjust and manage glycemic patterns by ensuring good injection technique and changing the insulin type, insulin dose, and timing of meals and exercise relative to insulin doses
  • Describe recent advances in insulin therapy and their implications for clinical practice

CME Accreditation and Designation Statements
This enduring material activity, Found in Translation: Insulin Therapy and Glycemic Pattern Recognition in Clinical Practice, has been reviewed and is acceptable for up to 2.5 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins January 26, 2013. Term of approval is for 1 year from this date with the option of yearly renewal. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Institute for Medical and Nursing Education, Inc (IMNE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

IMNE designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosures
In compliance with the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of IMNE to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All individuals involved in planning (eg, faculty, continuing education provider staff, and educational partner staff) are expected to disclose any significant financial relationships with commercial interests over the past 12 months. IMNE also requires that faculty identify and reference off-label product or investigational uses of pharmaceutical agents and medical devices.

In accordance with the ACCME Standards for Commercial Support, parallel documents from other accrediting bodies, and IMNE policy, identification, and resolution of conflict of interest have been made in the form of external peer review of educational content.

The following disclosures have been made.

Faculty
Sam Dagogo-Jack, MD, FRCP
Consultant: Amylin; Joslin Diabetes Center; Merck; Santarus
Grant/Research Support: Boehringer Ingelheim; Bristol-Myers Squibb/AstraZeneca; NIH/NIDDK; Novo Nordisk Inc.

Dr Dagogo-Jack has disclosed that he will not discuss investigational uses of therapies, products, or devices.

John E Anderson, MD
Advisory Board: Eli Lilly and Company; Sanofi US
Consultant: Sanofi US
Speakers Bureau: Novo Nordisk Inc.

Dr Anderson has disclosed that he will discuss investigational uses of therapies, products, or devices.

Javier Morales, MD
Advisory Board: Boehringer Ingelheim; Eli Lilly and Company; Lipo Science; Novo Nordisk Inc.
Consultant: Eli Lilly and Company; Novo Nordisk Inc.
Speakers Bureau: Lipo Science; Novo Nordisk Inc.; Warner Chilcott

Dr Morales has disclosed that he will discuss investigational uses of therapies, products, or devices.

Geralyn Spollett, MSN, ANP-CS, CDE
Advisory Board: Eli Lilly and Company; Sanofi US

Ms Spollett has disclosed that she will discuss investigational uses of therapies, products, or devices.

IMNE Staff
Amy Carbonara
Director, Program Development
Ms Carbonara has nothing to disclose.

Angela McIntosh, PhD
Scientific Director
Dr McIntosh has nothing to disclose.

Marge Tamas
Editorial Manager
Ms Tamas has nothing to disclose.

Steve Weinman, RN
Executive Director
Mr Weinman has nothing to disclose.

CME Peer Review
Martin Quan, MD
David Geffen School of Medicine at UCLA
Dr Quan has nothing to disclose.

Disclaimer
This activity is designed for HCPs for educational purposes. Information and opinions offered by the faculty/presenters represent their own viewpoints. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information.

While IMNE makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Commercial Support Acknowledgment:
This activity is supported by an educational grant from Novo Nordisk Inc.

Method of Participation:
To obtain CME credit, each participant should:

  • View the content presented
  • Answer all questions posed throughout the activity
  • Complete and submit the CME demographic, posttest, and evaluation form
  • Print the online CME certificate

This activity should take approximately 2.5 hours to complete. The expiration date for this activity is January 26, 2014. No credit will be granted after this date.

Minimum System Requirements:
The following system requirements are recommended for the best presentation viewing experience:

  • Microsoft Windows Vista, Windows 7, or Macintosh OS X 10.5 (Leopard)
  • Display resolution of 1024 x 768 or greater
    Windows compatible sound card
  • Microsoft Internet Explorer 8 or above on the PC, Safari version 5 on Mac
  • Windows Media Player 11
  • Broadband Internet connection (512 kbps & above)
  • Adobe Flash Player 10 or greater

If you have any questions about viewing the webcast please contact us.

 I have read and understand the CME Information indexed above.

Webcast

Click for presentation

CME Posttest and Evaluation

    •  
    • CME credit is offered upon successful completion of the posttest with a minimum passing score of 70%.
    •  
    • After completing the posttest and CME evaluation, a continuing education certificate will automatically be generated and should be printed or saved to your computer for your records.
    •  
    • Contact IMNE for questions regarding CME Credits: steve.weinman@imne.com.
    •  
    • CME Evaluation - This portion of the activity allows us to evaluate the types of healthcare professionals who are participating in the activity. This information will also be used to develop needs assessments for future educational programs on this topic. Thus, to the best of your ability, please respond with what you feel is the most accurate answer.
    •  
    • CME Posttest - This should be completed after the demographic questionnaire.
    •  
    •  
    • You must be signed in to WebBasedCME.com in order to participate and receive CME credit. New to WebBasedCME.com? Click here to register.